HOOKIPA Pharma Inc. (HOOK)

HOOKIPA Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-81.58	-64.92	-75.67	-44.08	-43.04
Depreciation & Amortization	3.55	3.6	4.64	4.15	3.07
Share-Based Compensation	2.35	5.04	7.64	8.66	5.57
Other Operating Activities	18.16	36.27	-2.64	-8.06	-7.33
Operating Cash Flow	-57.52	-20	-66.02	-39.34	-41.73
Capital Expenditures	-4.16	-5.02	-12.58	-2.37	-2
Investing Cash Flow	-4.16	-5.02	-12.58	-2.37	-2
Share Issuance / Repurchase	49.04	45.69	0.2	42.64	74.76
Debt Issued / Paid	-1.75	-2.85	-0.44	-1.42	-2.28
Other Financing Activities	18.38	29.43	-	32.2	37.27
Financing Cash Flow	65.67	72.27	-0.24	73.42	109.75
Exchange Rate Effect	0.09	-0.73	2.57	-2.11	-1.03
Net Cash Flow	3.99	47.26	-78.83	31.71	66.02
Free Cash Flow	-61.68	-25.01	-78.6	-41.71	-43.73
Free Cash Flow Margin	-306.44%	-175.55%	-426.05%	-212.98%	-366.19%
Free Cash Flow Per Share	-0.73	-0.46	-2.62	-1.63	-2.45

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).